HF/VAD/MCS/Transplant. Sarcoid, amyloid, genetics. Director, Infiltrative Cardiomyopathy Program @WestchesterMed @NYMedCollege Views / tweets are my own.
New York
Joined March 2009
- Tweets564
- Following899
- Followers934
- Likes3.7K
Steve Pan retweeted
#HCM, #sarcoidosis and #amyloid, oh my! How to tell the difference and work them up now that we have so many treatment options! @stephenpanmd @DeveshRaiMD @mmartinezheart @ChrisKramerMD @purviparwani @EllauziRama @nymedcollege @DrFuisz @tikuowens
pmc.ncbi.nlm.nih.gov/article…
Steve Pan retweeted
Farxiga is now $8/month on @costplusdrugs (or under $5 monthly if you get a 90 day supply)
The same medication on GoodRx? More than 10-20x that.
I'm a cardiologist. SGLT2 inhibitors keep my heart failure and kidney disease patients alive. Too many of them couldn't afford it before. Now they can.
Thank you @mcuban ! This changes things in a big way for my patients
gregorykatz.substack.com/p/i…
Steve Pan retweeted
This is my favorite study of the year.
What a waste of money. But keep telling physicians to see more patients every hour. Because that is working so well….
US nonprofit hospitals spent $7.8 billion on management consultants from 2009 to 2023, but contracts were not associated with meaningful changes in finance, operations, or quality of care. 🧵
ja.ma/4d46zfq
Looking forward to it!
🚨Calling all #MedTwitter #Cardiology enthusiasts🫀
Make sure to join @stephenpanmd and @sukritibanthiya for this exciting Cardiology VMR!
❤️ Monday, September 22nd @ 2PM PST/5PM EST
Steve Pan retweeted
A study found that primary care doctors need 26.7 hours per day to complete guideline-concordant care (14.1 hrs for preventive care, 7.2 for chronic disease care, 2.2 for acute care, & 3.2 for documentation & inbox).
Please take a moment to thank a primary care clinician today.
A great read. "Getting fired [by a patient] does not necessarily mean the clinician did wrong. Sometimes it means the clinician did what was needed." It was a privilege to learn from Bob Arnold at #PittMed
Why Good Palliative Care Clinicians Get Fired
jamanetwork.com/journals/jam…
Steve Pan retweeted
Highlights of #ISHLT2025
@WMCHealth Heart Failure Team and kind of reunion Masashi Kai from @BIDMCSurgery
@ameeshisath @stephenpanmd @VasilikiGreg
And later today former @WMCCardsFellows @ameeshisath now @MassGenBrigham HF fellow presenting data on sensitized patients undergoing #hearttransplant from DCD donors. #ISHLT2025 @WMCHealth @SuguruOhira
Kicking off the 1st day of #ISHLT2025 right with @WMCCardsFellows superstar Nathaniel Abittan presenting our excellent data from @WMCHealth #hearttransplant on the use of eculizumab in highly sensitized pts
Steve Pan retweeted
A monumental day for the #ATTR #amyloidosis field: #Vutrisiran is now FDA approved for ATTR-CM! The landmark #HELIOS-B trial hit 10/10 prespecified endpoints including improved all-cause mortality. Congratulations to everyone who contributed to the development/approval, and a special thanks to all of the patients who participated in the clinical trials. This is how #sciencemovesforward! 🍾businesswire.com/news/home/2…
Steve Pan retweeted
👏1 oral and 8 posters were accepted to @ISHLT meeting 2025 in Boston
Congratulations @ShazliKhanMD @ameeshisath , Nate, Caroline, and @nymedcollege students
@WMCCardsFellows @stephenpanmd @Transmedics @jjmt_heartrecov
Shout out to former @WMCCardsFellows and now @BrighamWomens CHF fellow @ameeshisath for spearheading this perspective piece on multidisciplinary palliative care in those on #impella 5.5 support, now out in JCF. A tough topic but he did a stellar job! authors.elsevier.com/c/1juoV…
Steve Pan retweeted
We now offer a treatment for arrhythmia patients w/o other options: cardiac radioablation. Electrophysiology + cardiology + radiation medicine offers new hope to patients w/limited options. A non-invasive, 45-minute procedure: bit.ly/3ZIpAPA. 866.962.4327
Steve Pan retweeted
Next from #HFSA LBCT..
HELIOS-B presented by @MathewMaurer & Dr. Jering w/ discussion by @JLRosenthal
HELIOS-B recently published showed vutrisiran, a subcutaneously administered RNAi agent in pts with ATTR-CM led to 🔽 risk of death & CV events compared to placebo
🧵 (1/4)
Steve Pan retweeted
@VasilikiGreg and @ameeshisath did a great job! published in @ArtifOrgans
@Transmedics @WMCCardsFellows @STS_CTsurgery @stephenpanmd @PJSpen1982 onlinelibrary.wiley.com/doi/…
Steve Pan retweeted
🚨 MAJOR news in the #ATTR #amyloidosis world! Today the much-anticipated HELIOS-B results were presented @escardio & simultaneously published in @NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran! Lowered CV events and All-Cause mortality in the overall population & as monotherapy. Now, let’s take a deep dive into the results… nejm.org/doi/full/10.1056/NE…
She’s a superstar!!!
@ShazliKhanMD did such a fantastic job with this episode on Cardionerds! If you haven’t yet, go check out the podcast and listen to @robmentz and @ShazliKhanMD talk to us about treating iron deficiency anemia in CHF!
@SrihariNaiduMD @stephenpanmd @DrFuisz @DrRhthm @seiiwaiEPmd